Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

10.78
Delayed Data
As of Oct 20
 +0.16 / +1.51%
Today’s Change
5.70
Today|||52-Week Range
11.34
+76.14%
Year-to-Date
Novo Nordisk Gets FDA Panel's OK for Diabetes Drug
Oct 20 / GuruFocus News - Paid Partner Content